The Ability of Vaping Technology to Deliver an Equivalent Respirable Dose of Beclomethasone Dipropionate Compared to Nebulization

<b>Background/Objectives</b>: This study focuses on the ability of vaping technology to deliver beclomethasone dipropionate compared to nebulization. <b>Methods</b>: An in vitro comparison of aerosol properties in terms of respirable dose with the Glass Twin Impinger and the mass median aerodynamic...

Descripció completa

Dades bibliogràfiques

Autors principals:	Cyrille Bruneau, Clément Mercier, Lara Leclerc, Jérémie Pourchez
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2024-10-01
Col·lecció:	Pharmaceutics
Matèries:	vaping drug delivery system jet nebulizer respirable dose aerosol therapy chronic respiratory diseases beclomethasone dipropionate
Accés en línia:	https://www.mdpi.com/1999-4923/16/11/1396
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!